Ignite Creation Date:
2024-05-06 @ 8:14 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06300424
Status:
RECRUITING
Last Update Posted:
2024-04-17
First Post:
2024-03-03
Brief Title:
Neoadjuvant Almonertinib Followed by Chemo-immunotherapy in II-IIIB EGFR-mutant NSCLC
Sponsor:
Organization:
Guangdong Provincial Peoples Hospital